Myriad Genetics, Inc.

NASDAQ:MYGN

Medical - Diagnostics & Research

Healthcare
$5.53 +3.20%

+$0.14 today

Market cap
$530.45M
Beta
1.64
P/E (TTM)
-1.1
EPS (TTM)
-$4.27
52W Low $3.53High $8.59

Volume 1.26M

Average 1.81M

MYGN Property, Plant & Equipment (Net)

Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.

Myriad Genetics, Inc.NASDAQ: MYGN

Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026

Property, plant & equipment (net) falls 2.9% from a year ago

Property, plant & equipment (net) stood at $162.5M at the end of Q1 FY2026, down 2.9% from a year earlier and down 0.6% from the prior quarter. Over 3 fiscal years it compounded at -4.4% a year.

Context

  • Property, plant & equipment (net) amounted to 24.1% of total assets at the end of Q1 FY2026, up 7.5 pp from a year earlier.
  • Property, plant & equipment (net) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -2.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$162.5M-0.6% QoQ
Last fiscal yearDec 2025
$163.4M-5.2% YoY
Year agoMar 2025
$167.4M-2.9% since
Property, Plant & Equipment (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.9%——
1 year-5.2%——
3-year CAGR-4.4%——
5-year CAGR——
10-year CAGR——

Property, Plant & Equipment (Net) history

USD · from the balance sheet

Latest · FY2025
163.4M USD
Year-over-year change
-5.2%
4-year CAGR
+6.9%

Property, Plant & Equipment (Net) vs competitors

How MYGN compares with its peers on the latest reported figures

  • MYGN's Mar 2026 property, plant & equipment (net) of $162.5M is the 5th highest of the 10 companies compared; the peer median is $124.03M.
  • Its year-over-year change of -2.9% is the lowest of 10, against a peer median of +5.5%.
  • Property, plant & equipment (net) amounts to 24.1% of total assets for MYGN, versus a peer median of 15.5%.
MYGN Competitors Peer median
Property, Plant & Equipment (Net) for MYGN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
QGENQiagen N.V.Jun 2026$923.04M +5.5%+11.7%15.7%
NTRANatera, Inc.Jun 2026$447.26M +57.3%+28.6%16.8%
GHGuardant Health, Inc.Sep 2026$292.72M +1.6%-3.8%15.5%
NEONeoGenomics, Inc.Jun 2026$166.2M -1.3%-6.3%12.3%
MYGNMyriad Genetics, Inc.Mar 2026$162.5M -2.9%-4.4%24.1%
FLGTFulgent Genetics, Inc.Mar 2026$124.03M +15.8%+11.4%10.7%
BLLNBillionToOne, Inc.Jun 2026$72.76M +6.4%—10.0%
PSNLPersonalis, Inc.Mar 2026$63.4M -1.0%-12.2%19.5%
VCYTVeracyte, Inc.Jun 2026$57.1M -0.2%+24.0%3.8%
IMDXInsight Molecular Diagnostics Inc.Mar 2026$8.91M +24.5%-36.2%22.0%
Peer median (excluding MYGN) $124.03M+5.5%+3.8%15.5%

Competitors are the stored peer set for MYGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents258.4M56.9M132.1M102.4M149.6M
Short-term Investments81.4M58M8.8M00
Net Receivables91.3M101.6M114.3M121.2M115.3M
Inventory15.3M20.1M22M27.5M30.6M
Other Current Assets38.4M20.4M19.4M30.5M37.1M
Total Current Assets484.8M274.6M313.6M298M332.6M
Property, Plant & Equipment (Net)125.3M187.3M180.6M172.4M163.4M
Goodwill239.2M286.8M287.4M286.3M51.6M
Intangible Assets404.1M379.7M349.5M262.4M153.4M
Long-term Investments59M54.8M000
Tax Assets00000
Other Non-current Assets8.3M15.5M15.4M8.5M5.6M
Total Non-current Assets835.9M924.1M832.9M729.6M374M
Total Assets1.32B1.2B1.15B1.03B706.6M
Account Payables29.6M28.8M25.8M32.3M30M
Short-term Debt13M14.1M006.9M
Tax Payables4M4.8M4.6M5.1M0
Deferred Revenue5.2M600K000
Other Current Liabilities126.9M64.9M38.2M64.9M96.9M
Total Current Liabilities204.3M137.2M155.9M164.1M133.8M
Long-term Debt79.3M130.9M38.5M39.6M202.9M
Deferred Tax Liabilities35.8M3.5M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities33.5M41.3M71.5M34.9M1.9M
Total Non-current Liabilities148.6M175.7M207.4M162.4M204.8M
Total Liabilities352.9M312.9M363.3M326.5M338.6M
Common Stock800K800K900K900K900K
Retained Earnings(254.2M)(366.2M)(629.5M)(756.8M)(1.12B)
Accumulated OCI(5.1M)(8.9M)(3.7M)(800K)800K
Other Stockholders Equity1.23B1.26B000
Minority Interest00000
Total Equity967.8M885.8M783.2M701.1M368M
Total Debt92.3M145M152.1M140.3M209.8M
Net Debt(166.1M)88.1M20M37.9M60.2M

Myriad Genetics, Inc.

NASDAQ:MYGN

Intrinsic Alpha fair value

Locked

Current Price

$5.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.